|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | A61K 31/05 | (2006.01) |
| A61K 31/08 | (2006.01) | ||
| A61K 31/192 | (2006.01) | ||
| A61K 31/352 | (2006.01) | ||
| A61K 31/485 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/555 | (2006.01) | ||
| A61K 31/7068 | (2006.01) |
| (11) | Patento numeris | 3937914 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20712673.1 |
| Europos patento paraiškos padavimo data | 2020-03-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2022-01-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-08-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2020/050638 |
| Data | 2020-03-13 |
| (87) | Numeris | WO 2020/188255 |
| Data | 2020-09-24 |
| (30) | Numeris | Data | Šalis |
| 201903546 | 2019-03-15 | GB |
| (72) |
LIU, Wai , GB
DALGLEISH, Angus , GB
|
| (73) |
LDN Pharma Limited ,
45 Gresham Street, London EC2V 7BG,
GB
|
| (54) | CANCER TREATMENT COMPRISING NALTREXONE AND A CANNABINOID |
| CANCER TREATMENT COMPRISING NALTREXONE AND A CANNABINOID |